Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cephalalgia : an International Journal of Headache|October 22, 2024
High-frequency episodic migraine: Time for its recognition as a migraine subtype?Francescantonio Cammarota, Roberto De Icco, Gloria Vaghi, et al.
The Journal of Headache and Pain|September 17, 2022
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trialRoberto De Icco, Gloria Vaghi, Marta Allena, et al.
Sensors (Basel, Switzerland)|September 28, 2024
Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced ImmunosuppressionLuca Martinis, Stefano Filippo Castiglia, Gloria Vaghi, et al.
The Journal of Headache and Pain|March 3, 2024
The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease studyMarta Waliszewska-Prosół, Danilo Antonio Montisano, Mariola Antolak, et al.
Cephalalgia : an International Journal of Headache|May 19, 2025
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trialRaffaele Ornello, Aurora D'Atri, Roberto De Icco, et al.
Cephalalgia : an International Journal of Headache|December 4, 2025
miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cellsRosaria Greco, Federico Bighiani, Chiara Demartini, et al.
The Journal of Headache and Pain|August 26, 2024
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profileRosaria Greco, Federico Bighiani, Chiara Demartini, et al.
Cephalalgia : an International Journal of Headache|August 7, 2025
Real world effectiveness of anti-CGRP monoclonal antibodies over three consecutive one-year treatment cycles: An intention-to-treat analysisGloria Vaghi, Michele Corrado, Maria Magdalena Pocora, et al.
Scientific Reports|April 9, 2024
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation settingGloria Vaghi, Andrea Morotti, Elisa Maria Piella, et al.
Gait & Posture|July 30, 2025
Clinical and instrumental gait phenotyping in people with GLUT-1 deficiency syndromeMichele Corrado, Valeria Vacchini, Massimiliano Celario, et al.
Pageof 1